Press release
-
Press Release
Urbana 25 Ignites Gen Z’s Search for Meaning and Mission
Thousands of Young Adults to Converge in Phoenix, AZ — December 28, 2025–January 1, 2026 PHOENIX, Dec. 5, 2025 /PRNewswire/…
Read More » -
Press Release
Trigent Partners with WeWork India to Expand its GCC Footprint
Strategic collaboration accelerates intelligence-driven Global Capability Centers bringing enterprise-grade processes, startup agility, and flexible workspaces SOUTHBOROUGH, Mass., Dec. 5, 2025…
Read More » -
Press Release
Astellas To Present New Data on XOSPATA™ (gilteritinib) Across the FLT3m+ AML Disease Continuum at ASH 2025 Annual Meeting
– Presentations include pooled post-hoc analysis of the Phase 3 ADMIRAL and COMMODORE data on post-transplant gilteritinib resumption in relapsed…
Read More » -
Press Release
AI Back-End Networks Continue Their Shift to Ethernet, Now Accounting for Over Two-Thirds of 3Q 2025 Switch Sales in AI Clusters, According to Dell’Oro Group
Accton, Arista, and Cisco Gained the Most Share, While Celestica and NVIDIA Continue toLead with Nearly 50 Percent Combined Share…
Read More » -
Press Release
Trumid Reports Record RFQ Volume in November
32% YoY platform growth driven by record client engagement in list-based protocols NEW YORK, Dec. 5, 2025 /PRNewswire/ — Trumid,…
Read More » -
Press Release
K36 Therapeutics announces presentation of First-in-Human Clinical Data for Gintemetostat (KTX-1001) Demonstrating Target Engagement and Clinical Activity in Multiple Myeloma at ASH 2025 and the Appointment of Dr. Shinta Cheng, M.D., Ph.D., as Chief Medical Officer
First-in-human data highlights safety, pharmacodynamics, and single-agent activity supporting MMSET/NSD2 inhibition in heavily pre-treated multiple myeloma patients Shinta Cheng, M.D.,…
Read More » -
Press Release
Bit Digital Inc. Reports Monthly Ethereum Treasury and Staking Metrics for November 2025
NEW YORK, Dec. 5, 2025 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”) today announced its…
Read More » -
Press Release
Jubilant Therapeutics Inc. appoints Daniel J. O’Connor as President and Chief Executive Officer
YARDLEY, Pa., Dec. 5, 2025 /PRNewswire/ — Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel small molecule modulators for…
Read More »
